Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid

Mutagenesis

Volumn 29, Issue 5, 2014, Pages 357-365

  Meng, Fanxue ^a   Li, Zhiguang ^b   Yan, Jian ^a   Manjanatha, Mugimane ^a   Shelton, Sharon ^a   Yarborough, Stephanie ^c   Chen, Tao ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; ARISTOLOCHIC ACID I; CARCINOGEN; MICRORNA; MIRN21 MICRORNA, RAT; MIRN34 MICRORNA, RAT; MUTAGENIC AGENT;

ANIMAL; DNA DAMAGE; DRUG EFFECTS; GENETICS; KIDNEY; LIVER; MALE; METABOLISM; MICROARRAY ANALYSIS; RAT; TESTIS; TRANSGENIC RAT; UPREGULATION;

ANIMALS; ARISTOLOCHIC ACIDS; CARCINOGENS; DNA DAMAGE; KIDNEY; LIVER; MALE; MICROARRAY ANALYSIS; MICRORNAS; MUTAGENS; RATS; RATS, TRANSGENIC; TESTIS; UP-REGULATION;

EID: 84906811010     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geu027     Document Type: Article

References (45)

1. Vishwanath, B. S., Appu Rao, A. G. and Gowda, T. V. (1987) Interaction of phospholipase A2 from Vipera russelli venom with aristolochic acid: a circular dichroism study. Toxicon, 25, 939-946.
2. IARC. (2002) Some Traditional Herbal Medicines, Some Mycotoxins, Nephthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 82, Lyon, France. http://monographs.iarc. fr/ENG/Monographs/vol82/ mono82.pdf (accessed March 3, 2014).
3. Nortier, J. L., Martinez, M. C., Schmeiser, H. H., et al. (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med., 342, 1686-1692.
4. Arlt, V. M., Alunni-Perret, V., Quatrehomme, G., et al. (2004) Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int. J. Cancer, 111, 977-980.
5. Schmeiser, H. H., Bieler, C. A., Wiessler, M., van Ypersele de Strihou, C. and Cosyns, J. P. (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res., 56, 2025-2028.
6. Mei, N., Arlt, V. M., Phillips, D. H., Heflich, R. H. and Chen, T. (2006) DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat. Res.-Fund. Mol. M, 602, 83-91.
7. Mei, N., Arlt, V. M., Phillips, D. H., Heflich, R. H. and Chen, T. (2006) DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat. Res., 602, 83-91.
8. Mengs, U., Lang, W. and Poch, J. A. (1982) The carcinogenic action of aristolochic in rats. Arch. Toxicol., 51, 107-119.
9. McDaniel, L. P., Elander, E. R., Guo, X., Chen, T., Arlt, V. M. and Mei, N. (2012) Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats. Environ. Mol. Mutagen., 53, 358-368.
10. Chen, T. (2010) The role of microRNA in chemical carcinogenesis. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Rev., 28, 89-124.
11. Bommer, G. T., Gerin, I., Feng, Y., et al. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol., 17, 1298-1307.
12. He, L., He, X., Lim, L. P., et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
13. Sun, F., Fu, H., Liu, Q., Tie, Y., Zhu, J., Xing, R., Sun, Z. and Zheng, X. (2008) Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett., 582, 1564-1568.
14. Tazawa, H., Tsuchiya, N., Izumiya, M. and Nakagama, H. (2007) Tumorsuppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA, 104, 15472-15477.
15. Volinia, S., Calin, G. A., Liu, C. G., et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
16. Gao, X., Gulari, E. and Zhou, X. (2004) In situ synthesis of oligonucleotide microarrays. Biopolymers, 73, 579-596.
17. Bolstad, B. M., Irizarry, R. A., Astrand, M. and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185-193.
18. Fang, H., Harris, S. C., Su, Z., Chen, M., Qian, F., Shi, L., Perkins, R. and Tong, W. (2009) ArrayTrack: an FDA and public genomic tool. Methods Mol. Biol., 563, 379-398.
19. Li, Z., Fuscoe, J. C. and Chen, T. (2011) MicroRNAs and their predicted target messenger RNAs are deregulated by exposure to a carcinogenic dose of comfrey in rat liver. Environ. Mol. Mutagen., 52, 469-478.
20. Li, Z., Branham, W. S., Dial, S. L., Wang, Y., Guo, L., Shi, L. and Chen, T. (2010) Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea. BMC Genomics, 11, 609.
21. Chen, T., Li, Z., Yan, J., Yang, X. and Salminen, W. (2012) MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis, 27, 59-66.
22. Hanel, W. and Moll, U. M. (2012) Links between mutant p53 and genomic instability. J. Cell. Biochem., 113, 433-439.
23. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G. and Hermeking, H. (2007) Differential regulation of micro- RNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 6, 1586-1593.
24. Pichiorri, F., Suh, S. S., Rocci, A., et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell, 18, 367-381.
25. Luan, Y., Qi, X., Xu, L., Ren, J., and Chen, T. (2014) Absence of mature microRNAs inactivates the response of gene expression to carcinogenesis induced by N-ethyl-N-nitrosourea in mouse liver. J. Appl. Toxicol 2014 January 30 [Epub ahead of print], doi:10.1002/jat.2973.
26. Dey, N., Das, F., Ghosh-Choudhury, N., Mandal, C. C., Parekh, D. J., Block, K., Kasinath, B. S., Abboud, H. E. and Choudhury, G. G. (2012) MicroRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One, 7, e37366.
27. Hirata, H., Ueno, K., Shahryari, V., Tanaka, Y., Tabatabai, Z. L., Hinoda, Y. and Dahiya, R. (2012) Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One, 7, e51056.
28. Yamamura, S., Saini, S., Majid, S., Hirata, H., Ueno, K., Chang, I., Tanaka, Y., Gupta, A. and Dahiya, R. (2012) MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis, 33, 294-300.
29. White, N. M., Bao, T. T., Grigull, J., et al. (2011) miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J. Urol., 186, 1077-1083.
30. Chen, L., Mei, N., Yao, L. and Chen, T. (2006) Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats. Toxicol. Lett., 165, 250-256.
31. Malik, A. I., Rowan-Carroll, A., Williams, A., Lemieux, C. L., Long, A. S., Arlt, V. M., Phillips, D. H., White, P. A. and Yauk, C. L. (2013) Hepatic genotoxicity and toxicogenomic responses in Muta™Mouse males treated with dibenz[a, h]anthracene. Mutagenesis, 28, 543-554.
32. Malik, A. I., Williams, A., Lemieux, C. L., White, P. A. and Yauk, C. L. (2012) Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation. Environ. Mol. Mutagen., 53, 10-21.
33. Pogribny, I. P., Muskhelishvili, L., Tryndyak, V. P. and Beland, F. A. (2009) The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol., 235, 305-311.
34. Pogribny, I. P., Tryndyak, V. P., Boyko, A., Rodriguez-Juarez, R., Beland, F. A. and Kovalchuk, O. (2007) Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat. Res., 619, 30-37.
35. Chen, Y. Y., Chung, J. G., Wu, H. C., Bau, D. T., Wu, K. Y., Kao, S. T., Hsiang, C. Y., Ho, T. Y. and Chiang, S. Y. (2010) Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells. Oncol. Rep., 24, 141-153.
36. Kaller, M., Liffers, S. T., Oeljeklaus, S., Kuhlmann, K., Röh, S., Hoffmann, R., Warscheid, B. and Hermeking, H. (2011) Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol. Cell. Proteomics, 10, M111.010462.
37. Yamakuchi, M., Ferlito, M. and Lowenstein, C. J. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA, 105, 13421-13426.
38. Faragalla, H., Youssef, Y. M., Scorilas, A., et al. (2012) The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J. Mol. Diagn., 14, 385-392.
39. Fu, C., Dong, W., Wang, Z., Li, H., Qin, Q. and Li, B. (2014) The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. Biochem. Biophys. Res. Commun., 446, 1197-1203.
40. Ge, W., Yu, D. C., Li, Q. G., Chen, X., Zhang, C. Y. and Ding, Y. T. (2014) Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. Clin. Lab., 60, 427-434.
41. Zhong, Z., Dong, Z., Yang, L. and Gong, Z. (2012) miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J. Cancer Res. Clin. Oncol., 138, 1781-1788.
42. Kim, Y. J., Hwang, S. J., Bae, Y. C. and Jung, J. S. (2009) MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells, 27, 3093-3102.
43. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S. and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
44. Huang, T. H., Wu, F., Loeb, G. B., et al. (2009) Up-regulation of miR- 21 by HER2/neu signaling promotes cell invasion. J. Biol. Chem., 284, 18515-18524.
45. Valeri, N., Gasparini, P., Braconi, C., et al. (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc. Natl Acad. Sci. USA, 107, 21098-21103.